Related references
Note: Only part of the references are listed.Immunotherapy of Melanoma: Facts and Hopes
Sarah A. Weiss et al.
CLINICAL CANCER RESEARCH (2019)
Platelet count correlates with stage and predicts survival in melanoma
Saleh Rachidi et al.
PLATELETS (2019)
TMOD-30. TARGETING AN OLIG2-DEPENDENT PATHWAY TO INHIBIT TUMOR GROWTH IN PRIMARY AND RECURRENT MEDULLOBLASTOMA
Xuelian He et al.
NEURO-ONCOLOGY (2017)
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
Silvia Juliana Serrano-Gomez et al.
MOLECULAR CANCER (2016)
Epithelial-mesenchymal transition: a new target in anticancer drug discovery
Fabrizio Marcucci et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
AP-1/c-Jun transcription factors: Regulation and function in malignant melanoma
Melanie Kappelmann et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2014)
Oncogenic roles of EMT-inducing transcription factors
Alain Puisieux et al.
NATURE CELL BIOLOGY (2014)
BRAF Inhibitors Induce Metastasis in RAS Mutant or Inhibitor-Resistant Melanoma Cells By Reactivating MEK and ERK Signaling
Berta Sanchez-Laorden et al.
SCIENCE SIGNALING (2014)
The Central Nervous System-Restricted Transcription Factor Olig2 Opposes p53 Responses to Genotoxic Damage in Neural Progenitors and Malignant Glioma
Shwetal Mehta et al.
CANCER CELL (2011)
Phosphorylation State of Olig2 Regulates Proliferation of Neural Progenitors
Yu Sun et al.
NEURON (2011)
BRAF as therapeutic target in melanoma
Claudia Wellbrock et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Regulation of the Apaf-1-caspase-9 apoptosome
Shawn B. Bratton et al.
JOURNAL OF CELL SCIENCE (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Epidemiology of invasive cutaneous melanoma
R. M. MacKie et al.
ANNALS OF ONCOLOGY (2009)
Bcl2 family proteins in carcinogenesis and the treatment of cancer
Anna Frenzel et al.
APOPTOSIS (2009)
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma
Michael A. Davies et al.
CLINICAL CANCER RESEARCH (2009)
A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis
J. S. Blackburn et al.
ONCOGENE (2009)
Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression
Zhou Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma
Keith L. Ligon et al.
NEURON (2007)
MITF: master regulator of melanocyte development and melanoma oncogene
Carmit Levy et al.
TRENDS IN MOLECULAR MEDICINE (2006)
The antioxidant function of the p53 tumor suppressor
AA Sablina et al.
NATURE MEDICINE (2005)
OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1
YW Lin et al.
CANCER RESEARCH (2005)
Unraveling signalling cascades for the Snail family of transcription factors
B De Craene et al.
CELLULAR SIGNALLING (2005)
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis
JE Chipuk et al.
SCIENCE (2004)
ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway
T Ohtsuka et al.
NATURE CELL BIOLOGY (2004)
Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells -: Role of BRAF mutation and fibroblast growth factor signaling
JT Huntington et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Determinants of BRAF mutations in primary melanomas
JL Maldonado et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Regulation of the Apaf-1/Caspase-9 apoptosome by caspase-3 and XIAP
H Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer
Y Hinoda et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The basic helix-loop-helix factor Olig2 is essential for the development of motoneuron and oligodendrocyte lineages
H Takebayashi et al.
CURRENT BIOLOGY (2002)
The role of chemokines in melanoma tumor growth and metastasis
AS Payne et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification
Q Zhou et al.
CELL (2002)
Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; Protection by the MMP inhibitor, doxycycline
DM Roach et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2002)
Share Paper
